SEC Form 4 · accession 0001225208-16-036934
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin J. Ballinger
Officer — SVP & Pres, Interven Cardio
Period of report
Jul 20, 2016
Accepted (ET)
Jul 21, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 20, 2016 | M | 78,122 | $6.31 | A | 125,092 | D | |
| Common StockF2 | Jul 20, 2016 | S | 78,122 | $24.03 | D | 46,970 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $6.31 | Jul 20, 2016 | M | 78,122 | D | — | Oct 25, 2020 | Common Stock | 78,122 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F3Grant to the reporting person of an option to purchase a specified number of shares of common stock on October 25, 2010. This option is fully vested.